BVXV Annual Accounts Payable
$716.00 K
-$283.00 K-28.33%
31 December 2022
Summary:
As of February 5, 2025, BVXV annual accounts payable is $716.00 thousand, with the most recent change of -$283.00 thousand (-28.33%) on December 31, 2022. During the last 3 years, it has fallen by -$4.21 million (-85.47%).BVXV Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BVXV Quarterly Accounts Payable
$651.00 K
-$662.00 K-50.42%
30 June 2023
Summary:
As of February 5, 2025, BVXV quarterly accounts payable is $651.00 thousand, with the most recent change of -$662.00 thousand (-50.42%) on June 30, 2023. Over the past year, it has increased by +$58.60 thousand (+9.89%).BVXV Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BVXV Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.3% | +9.9% |
| 3 y3 years | -85.5% | -44.9% |
| 5 y5 years | -60.0% | +80.0% |
BVXV Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -87.0% | -88.2% |
BiondVax Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $651.00 K(-50.4%) |
| Mar 2023 | - | $1.31 M(+83.4%) |
| Dec 2022 | $716.00 K(-28.3%) | $716.00 K(+142.1%) |
| Sept 2022 | - | $295.70 K(-50.1%) |
| June 2022 | - | $592.40 K(-54.1%) |
| Mar 2022 | - | $1.29 M(+29.1%) |
| Dec 2021 | $999.00 K(+72.0%) | $999.00 K(-2.9%) |
| Sept 2021 | - | $1.03 M(+27.1%) |
| June 2021 | - | $809.30 K(+29.6%) |
| Mar 2021 | - | $624.40 K(+7.5%) |
| Dec 2020 | $580.90 K(-88.2%) | $580.90 K(-75.6%) |
| Sept 2020 | - | $2.38 M(+101.7%) |
| June 2020 | - | $1.18 M(+28.6%) |
| Mar 2020 | - | $918.10 K(-81.4%) |
| Dec 2019 | $4.93 M(-10.5%) | $4.93 M(+1006.0%) |
| Sept 2019 | - | $445.50 K(-80.0%) |
| June 2019 | - | $2.23 M(-46.9%) |
| Mar 2019 | - | $4.20 M(-23.6%) |
| Dec 2018 | $5.50 M | $5.50 M(+1047.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $479.40 K(+32.5%) |
| June 2018 | - | $361.70 K(-85.1%) |
| Mar 2018 | - | $2.43 M(+35.6%) |
| Dec 2017 | $1.79 M(+904.2%) | $1.79 M(+697.9%) |
| Sept 2017 | - | $224.40 K(-34.1%) |
| June 2017 | - | $340.60 K(+64.1%) |
| Mar 2017 | - | $207.50 K(+16.4%) |
| Dec 2016 | $178.30 K(-25.2%) | $178.30 K(+40.4%) |
| Sept 2016 | - | $127.00 K(+7.2%) |
| June 2016 | - | $118.50 K(-46.4%) |
| Mar 2016 | - | $221.10 K(-7.3%) |
| Dec 2015 | $238.50 K(+77.2%) | $238.50 K(+64.1%) |
| Sept 2015 | - | $145.30 K(-13.5%) |
| June 2015 | - | $168.00 K(-14.1%) |
| Mar 2015 | - | $195.60 K(+45.3%) |
| Dec 2014 | $134.60 K(+19.5%) | $134.60 K(+66.0%) |
| Sept 2014 | - | $81.10 K(-28.0%) |
| Dec 2013 | $112.60 K(+4.2%) | $112.60 K |
| Dec 2012 | $108.10 K | - |
FAQ
- What is BiondVax Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals annual accounts payable year-on-year change?
- What is BiondVax Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals quarterly accounts payable year-on-year change?
What is BiondVax Pharmaceuticals annual accounts payable?
The current annual accounts payable of BVXV is $716.00 K
What is the all time high annual accounts payable for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high annual accounts payable is $5.50 M
What is BiondVax Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, BVXV annual accounts payable has changed by -$283.00 K (-28.33%)
What is BiondVax Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of BVXV is $651.00 K
What is the all time high quarterly accounts payable for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high quarterly accounts payable is $5.50 M
What is BiondVax Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, BVXV quarterly accounts payable has changed by +$58.60 K (+9.89%)